AnorMED to transfer listing to Nasdaq, registers $100 million stock shelf

By Laura Lutz

Des Moines, Aug. 24 - AnorMED Inc. received permission from the Nasdaq Stock Market, Inc. to list its common shares on the Nasdaq Global Market under the symbol "ANOR," according to an AnorMED release.

The company's shares are currently listed on the American Stock Exchange under the symbol "AOM." The shares will be delisted from the American Stock Exchange when they are listed on the Nasdaq market.

The shares will continue to trade on the Toronto Stock Exchange under the symbol "AOM."

AnorMED expects that transferring its listing will "provide the company with enhanced access to the broader capital markets in connection with potential future stock offerings," according to the release.

The company also registered $100 million of common shares in an F-10 filing with the Securities and Exchange Commission and in a preliminary short form base shelf prospectus with regulatory authorities in Canada.

The registered shares may be issued in one or more offerings over the next 25 months.

The proceeds will be used for working capital and for general corporate purposes.

Langley, B.C.-based AnorMED focuses on the discovery, development and commercialization of new therapeutics based on chemokine receptors in the areas of hematology, oncology and HIV.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.